Milind Deshpande

2011

In 2011, Milind Deshpande earned a total compensation of $1.1M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 18% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$144,536
Option Awards$555,511
Salary$359,975
Other$7,703
Total$1,067,725

Deshpande received $555.5K in option awards, accounting for 52% of the total pay in 2011.

Deshpande also received $144.5K in non-equity incentive plan, $360K in salary and $7.7K in other compensation.

Rankings

In 2011, Milind Deshpande's compensation ranked 5,418th out of 10,747 executives tracked by ExecPay. In other words, Deshpande earned more than 49.6% of executives.

ClassificationRankingPercentile
All
5,418
out of 10,747
50th
Division
Manufacturing
1,961
out of 3,960
51st
Major group
Chemicals And Allied Products
428
out of 1,033
59th
Industry group
Drugs
268
out of 781
66th
Industry
Pharmaceutical Preparations
209
out of 571
63rd
Source: SEC filing on April 18, 2014.

Deshpande's colleagues

We found five more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2011.

2011

Michael Kishbauch

Achillion Pharmaceuticals

Chief Executive Officer

2011

Elizabeth Olek

Achillion Pharmaceuticals

Chief Medical Officer

2011

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2011

Gautam Shah

Achillion Pharmaceuticals

Executive Vice President and Chief Compliance Officer

2011

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like